BIIB
Biogen (BIIB)
NASDAQ
$254.09+$0.69 (+0.27%)
Price as of Nov 12, 2026 8:48 AM EST
  • $37.5B
    Market Cap
  • 56.92%
    1-Year Change
  • Drug Manufacturers - General
    Industry

Earnings Score

Score: 39
Valuation
BIIB
vs History
vs S&P 500
Profitability
-1
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 64
Valuation
BIIB
vs History
vs S&P 500
3-Month Momentum
12.27%
12-Month Momentum
43.46%
3-Month Risk Adjusted Momentum
112.77%
12-Month Risk Adjusted Momentum
132.75%

True Yield

N/A
Valuation
BIIB
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
1.44%

Financial Health Score

Score: 5
Valuation
BIIB
vs History
vs S&P 500
Ohlson's O-Score
7